Introduction: Dyslipidemia is a significant cardiovascular risk factor in patients with type 2 diabetes. The objective of this study was to determine the prevalence of dyslipidemia among type 2 diabetics at the Sylvanus Olympio University Hospital in Lome and establish their lipid profile. Methods: A cross-sectional, descriptive study conducted over a 12-month period (July 1, 2022, to June 30, 2023) among type 2 diabetic patients seen in internal medicine consultations at the Military Medical-Surgical Clinic of the Sylvanus Olympio University Hospital in Lome. The data studied were demographic data and lipid profiles. Results: A total of one hundred and thirty-one patients were included, with a female predominance (59.54%). The mean age was 58.72 years (39 - 85 years). The mean blood glucose level was 1.97 g/l (0.65 - 4.50 g/l) and the mean glycated hemoglobin was 9.07% (5% - 15.1%). Dyslipidemia was found in 89 patients (67.94%). Low HDL cholesterol was predominant (39.69%), followed by hypertriglyceridemia (27.48%). High LDL cholesterol was found in 20.61% of cases and mixed dyslipidemia in 16.03%. The other cardiovascular risk factors identified were: hypertension (73.28%), obesity (29.01%), alcohol consumption (25.19%), and physical inactivity (12.21%). Conclusion: Dyslipidemia is frequent in our type 2 diabetic patients, predominantly characterized by low HDL cholesterol and hypertriglyceridemia.
References
[1]
International Diabetes Federation (2025) IDF Diabetes Atlas. 11th Edition, International Diabetes Federation. https://diabetesatlas.org
[2]
Durrington, P. (2007) Hyperlipidaemia 3Ed: Diagnosis and Management. 3rd Edition, CRC Press. https://doi.org/10.1201/b13464
[3]
Laing, S.P., Swerdlow, A.J., Slater, S.D., Burden, A.C., Morris, A., Waugh, N.R., et al. (2003) Mortality from Heart Disease in a Cohort of 23,000 Patients with Insulin-Treated Diabetes. Diabetologia, 46, 760-765. https://doi.org/10.1007/s00125-003-1116-6
[4]
Chapman, M.J., Ginsberg, H.N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A.L., et al. (2011) Triglyceride-rich Lipoproteins and High-Density Lipoprotein Cholesterol in Patients at High Risk of Cardiovascular Disease: Evidence and Guidance for Management. European Heart Journal, 32, 1345-1361. https://doi.org/10.1093/eurheartj/ehr112
[5]
West, K.M., Ahuja, M.M.S., Bennett, P.H., Czyzyk, A., De Acosta, O.M., Fuller, J.H., et al. (1983) The Role of Circulating Glucose and Triglyceride Concentrations and Their Interactions with Other “Risk Factors” as Determinants of Arterial Disease in Nine Diabetic Population Samples from the WHO Multinational Study. Diabetes Care, 6, 361-369. https://doi.org/10.2337/diacare.6.4.361
[6]
Howard, B.V., Robbins, D.C., Sievers, M.L., Lee, E.T., Rhoades, D., Devereux, R.B., et al. (2000) LDL Cholesterol as a Strong Predictor of Coronary Heart Disease in Diabetic Individuals with Insulin Resistance and Low LDL. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 830-835. https://doi.org/10.1161/01.atv.20.3.830
[7]
Taskinen, M. (2003) Diabetic Dyslipidaemia: From Basic Research to Clinical Practice. Diabetologia, 46, 733-749. https://doi.org/10.1007/s00125-003-1111-y
[8]
Kerekou, A., Dedjan, A.H. and Tchede, O. (2023) Les dyslipidémies chez les patients diabétiques de type 2 au CNHU-HKM de Cotonou. Annales d’Endocrinologie, 84, 680. https://doi.org/10.1016/j.ando.2023.07.498
[9]
Mbaye, A., Yaméogo, N.V.A.D., Diack, A., Ndiaye, M.B., Diack, B. and Pessinaba, S. (2010) Lipid Profile and Cardiovascular Risk of Type 2 Diabetic in Senegal. Angéiolo-gie (Artères), 62, 25-29.
[10]
Trabelsi, S., Ben Othman, R., Jallouli, Y., Mizouri, R., Berriche, O., Mahjoub, F., et al. (2024) Dyslipidémie et conséquences cardiovasculaires chez les diabétiques de type 2. Annales d’Endocrinologie, 85, 503. https://doi.org/10.1016/j.ando.2024.08.407
[11]
Sawadogo, N., Ouedraogo, S., Bamouni, J., Ouedraogo, W.M.E., Kabre, W.J. and Guira, O. (2023) Lipid Profile of Diabetic and Obese Patients at the Regional University Hospital of Ouahigouya. Health Sciences and Disease, 24, 23-27.
[12]
Harris, S.B., Ekoé, J., Zdanowicz, Y. and Webster-Bogaert, S. (2005) Glycemic Control and Morbidity in the Canadian Primary Care Setting (Results of the Diabetes in Canada Evaluation Study). Diabetes Research and Clinical Practice, 70, 90-97. https://doi.org/10.1016/j.diabres.2005.03.024
[13]
Hinneh, T., Akyirem, S., Bossman, I.F., Lambongang, V., Ofori-Aning, P., Ogungbe, O., et al. (2023) Regional Prevalence of Hypertension among People Diagnosed with Diabetes in Africa, a Systematic Review and Meta-Analysis. PLOS Global Public Health, 3, e0001931. https://doi.org/10.1371/journal.pgph.0001931
[14]
Ekpor, E., Akyirem, S. and Adade Duodu, P. (2023) Prevalence and Associated Factors of Overweight and Obesity among Persons with Type 2 Diabetes in Africa: A Systematic Review and Meta-Analysis. Annals of Medicine, 55, 696-713. https://doi.org/10.1080/07853890.2023.2182909
[15]
Reardon, T., Tschirley, D., Liverpool-Tasie, L.S.O., Awokuse, T., Fanzo, J., Minten, B., et al. (2021) The Processed Food Revolution in African Food Systems and the Double Burden of Malnutrition. Global Food Security, 28, Article ID: 100466. https://doi.org/10.1016/j.gfs.2020.100466
[16]
Reiger, S., Jardim, T.V., Abrahams-Gessel, S., Crowther, N.J., Wade, A., Gomez-Olive, F.X., et al. (2017) Awareness, Treatment, and Control of Dyslipidemia in Rural South Africa: The HAALSI (Health and Aging in Africa: A Longitudinal Study of an INDEPTH Community in South Africa) Study. PLOS ONE, 12, e0187347. https://doi.org/10.1371/journal.pone.0187347
[17]
Vergès, B. (2015) Pathophysiology of Diabetic Dyslipidaemia: Where Are We? Diabetologia, 58, 886-899. https://doi.org/10.1007/s00125-015-3525-8
[18]
Saydah, S.H., Fradkin, J. and Cowie, C.C. (2004) Poor Control of Risk Factors for Vascular Disease among Adults with Previously Diagnosed Diabetes. JAMA, 291, 335-342. https://doi.org/10.1001/jama.291.3.335
[19]
U.K. Prospective Diabetes Study Group (1997) U.K. Prospective Diabetes Study 27: Plasma Lipids and Lipoproteins at Diagnosis of NIDDM by Age and Sex. Diabetes Care, 20, 1683-1687. https://doi.org/10.2337/diacare.20.11.1683
[20]
Malmström, R., Packard, C.J., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., et al. (1997) Defective Regulation of Triglyceride Metabolism by Insulin in the Liver in NIDDM. Diabetologia, 40, 454-462. https://doi.org/10.1007/s001250050700
[21]
Krauss, R.M. and Siri, P.W. (2004) Dyslipidemia in Type 2 Diabetes. Medical Clinics of North America, 88, 897-909. https://doi.org/10.1016/j.mcna.2004.04.004
[22]
Duvillard, L., Pont, F., Florentin, E., Gambert, P. and Vergès, B. (2000) Inefficiency of Insulin Therapy to Correct Apolipoprotein A-I Metabolic Abnormalities in Non-Insulin-Dependent Diabetes Mellitus. Atherosclerosis, 152, 229-237. https://doi.org/10.1016/s0021-9150(99)00473-6
[23]
Perségol, L., Vergès, B., Foissac, M., Gambert, P. and Duvillard, L. (2006) Inability of HDL from Type 2 Diabetic Patients to Counteract the Inhibitory Effect of Oxidised LDL on Endothelium-Dependent Vasorelaxation. Diabetologia, 49, 1380-1386. https://doi.org/10.1007/s00125-006-0244-1
[24]
Sorrentino, S.A., Besler, C., Rohrer, L., Meyer, M., Heinrich, K., Bahlmann, F.H., et al. (2010) Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients with Type 2 Diabetes Mellitus but Are Improved after Extended-Release Niacin Therapy. Circulation, 121, 110-122. https://doi.org/10.1161/circulationaha.108.836346
[25]
Duvillard, L., Pont, F., Florentin, E., Galland‐Jos, C., Gambert, P. and Vergès, B. (2000) Metabolic Abnormalities of Apolipoprotein B-Containing Lipoproteins in Non-Insulin-Dependent Diabetes: A Stable Isotope Kinetic Study. European Journal of Clinical Investigation, 30, 685-694. https://doi.org/10.1046/j.1365-2362.2000.00755.x
[26]
Duvillard, L., Florentin, E., Lizard, G., Petit, J., Galland, F., Monier, S., et al. (2003) Cell Surface Expression of LDL Receptor Is Decreased in Type 2 Diabetic Patients and Is Normalized by Insulin Therapy. Diabetes Care, 26, 1540-1544. https://doi.org/10.2337/diacare.26.5.1540
[27]
Galland, F., Duvillard, L., Petit, J., Lagrost, L., Vaillant, G., Brun, J., et al. (2006) Effect of Insulin Treatment on Plasma Oxidized LDL/LDL-Cholesterol Ratio in Type 2 Diabetic Patients. Diabetes & Metabolism, 32, 625-631. https://doi.org/10.1016/s1262-3636(07)70318-x
[28]
Qiao, L., Zou, C., van der Westhuyzen, D.R. and Shao, J. (2008) Adiponectin Reduces Plasma Triglyceride by Increasing VLDL Triglyceride Catabolism. Diabetes, 57, 1824-1833. https://doi.org/10.2337/db07-0435
